Iron-Gallic Acid Peptide Nanoparticles as a Versatile Platform for Cellular Delivery with Synergistic ROS Enhancement Effect
-
Published:2023-06-21
Issue:7
Volume:15
Page:1789
-
ISSN:1999-4923
-
Container-title:Pharmaceutics
-
language:en
-
Short-container-title:Pharmaceutics
Author:
Shen Faqian1ORCID, Lin Yi1ORCID, Höhn Miriam1, Luo Xianjin1, Döblinger Markus2ORCID, Wagner Ernst1ORCID, Lächelt Ulrich13
Affiliation:
1. Pharmaceutical Biotechnology, Department of Pharmacy, Center for NanoScience (CeNS), LMU Munich, 81377 Munich, Germany 2. Department of Chemistry, LMU Munich, 81377 Munich, Germany 3. Department of Pharmaceutical Sciences, University of Vienna, 1090 Vienna, Austria
Abstract
Cytosolic delivery of peptides is of great interest owing to their biological functions, which could be utilized for therapeutic applications. However, their susceptibility to enzymatic degradation and multiple cellular barriers generally hinders their clinical application. Integration into nanoparticles, which can enhance the stability and membrane permeability of bioactive peptides, is a promising strategy to overcome extracellular and intracellular obstacles. Herein, we present a versatile platform for the cellular delivery of various cargo peptides by integration into metallo-peptidic coordination nanoparticles. Both termini of cargo peptides were conjugated with gallic acid (GA) to assemble GA-modified peptides into nanostructures upon coordination of Fe(III). Initial pre-complexation of Fe(III) by poly-(vinylpolypyrrolidon) (PVP) as a template favored the formation of nanoparticles, which are able to deliver the peptides into cells efficiently. Iron–gallic acid peptide nanoparticles (IGPNs) are stable in water and are supposed to generate reactive oxygen species (ROS) from endogenous H2O2 in cells via the Fenton reaction. The strategy was successfully applied to an exemplary set of peptide sequences varying in length (1–7 amino acids) and charge (negative, neutral, positive). To confirm the capability of transporting bioactive cargos into cells, pro-apoptotic peptides were integrated into IGPNs, which demonstrated potent killing of human cervix carcinoma HeLa and murine neuroblastoma N2a cells at a 10 µM peptide concentration via the complementary mechanisms of peptide-triggered apoptosis and Fe(III)-mediated ROS generation. This study demonstrates the establishment of IGPNs as a novel and versatile platform for the assembly of peptides into nanoparticles, which can be used for cellular delivery of bioactive peptides combined with intrinsic ROS generation.
Funder
University of Vienna
Subject
Pharmaceutical Science
Reference48 articles.
1. Holz, E., Darwish, M., Tesar, D.B., and Shatz-Binder, W. (2023). A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future. Pharmaceutics, 15. 2. Peptides as a Platform for Targeted Therapeutics for Cancer: Peptide-Drug Conjugates (PDCs);Cooper;Chem. Soc. Rev.,2021 3. Trends in Peptide Drug Discovery;Muttenthaler;Nat. Rev. Drug Discov.,2021 4. Molecular Engineering Solutions for Therapeutic Peptide Delivery;Acar;Chem. Soc. Rev.,2017 5. Apostolopoulos, V., Bojarska, J., Chai, T.T., Elnagdy, S., Kaczmarek, K., Matsoukas, J., New, R., Parang, K., Lopez, O.P., and Parhiz, H. (2021). A Global Review on Short Peptides: Frontiers and Perspectives. Molecules, 26.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|